These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

678 related articles for article (PubMed ID: 33178682)

  • 41. Diagnostic value of cerebrospinal fluid alpha-synuclein seed quantification in synucleinopathies.
    Poggiolini I; Gupta V; Lawton M; Lee S; El-Turabi A; Querejeta-Coma A; Trenkwalder C; Sixel-Döring F; Foubert-Samier A; Pavy-Le Traon A; Plazzi G; Biscarini F; Montplaisir J; Gagnon JF; Postuma RB; Antelmi E; Meissner WG; Mollenhauer B; Ben-Shlomo Y; Hu MT; Parkkinen L
    Brain; 2022 Apr; 145(2):584-595. PubMed ID: 34894214
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Parkinson's disease: acid-glucocerebrosidase activity and alpha-synuclein clearance.
    Blanz J; Saftig P
    J Neurochem; 2016 Oct; 139 Suppl 1():198-215. PubMed ID: 26860955
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The link between neuroinflammation and the neurovascular unit in synucleinopathies.
    Wang Q; Zheng J; Pettersson S; Reynolds R; Tan EK
    Sci Adv; 2023 Feb; 9(7):eabq1141. PubMed ID: 36791205
    [TBL] [Abstract][Full Text] [Related]  

  • 44. From inflammasome to Parkinson's disease: Does the NLRP3 inflammasome facilitate exosome secretion and exosomal alpha-synuclein transmission in Parkinson's disease?
    Si XL; Fang YJ; Li LF; Gu LY; Yin XZ; Jun-Tian ; Yan YP; Pu JL; Zhang BR
    Exp Neurol; 2021 Feb; 336():113525. PubMed ID: 33161049
    [TBL] [Abstract][Full Text] [Related]  

  • 45. α-Synuclein vaccination modulates regulatory T cell activation and microglia in the absence of brain pathology.
    Christiansen JR; Olesen MN; Otzen DE; Romero-Ramos M; Sanchez-Guajardo V
    J Neuroinflammation; 2016 Apr; 13(1):74. PubMed ID: 27055651
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Alpha-synucleinopathy reduces NMNAT3 protein levels and neurite formation that can be rescued by targeting the NAD+ pathway.
    Parsons RB; Kocinaj A; Ruiz Pulido G; Prendergast SA; Parsons AE; Facey PD; Hirth F
    Hum Mol Genet; 2022 Aug; 31(17):2918-2933. PubMed ID: 35397003
    [TBL] [Abstract][Full Text] [Related]  

  • 47. An Update on the Critical Role of α-Synuclein in Parkinson's Disease and Other Synucleinopathies: from Tissue to Cellular and Molecular Levels.
    Serratos IN; Hernández-Pérez E; Campos C; Aschner M; Santamaría A
    Mol Neurobiol; 2022 Jan; 59(1):620-642. PubMed ID: 34750787
    [TBL] [Abstract][Full Text] [Related]  

  • 48. α-Synuclein oligomers and fibrils: partners in crime in synucleinopathies.
    Bigi A; Cascella R; Cecchi C
    Neural Regen Res; 2023 Nov; 18(11):2332-2342. PubMed ID: 37282450
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Aggregation and beyond: alpha-synuclein-based biomarkers in synucleinopathies.
    Chopra A; Outeiro TF
    Brain; 2024 Jan; 147(1):81-90. PubMed ID: 37526295
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Gastric Enteric Glial Cells: A New Contributor to the Synucleinopathies in the MPTP-Induced Parkinsonism Mouse.
    Heng Y; Li YY; Wen L; Yan JQ; Chen NH; Yuan YH
    Molecules; 2022 Nov; 27(21):. PubMed ID: 36364248
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Alpha and Beta Synucleins: From Pathophysiology to Clinical Application as Biomarkers.
    Barba L; Paolini Paoletti F; Bellomo G; Gaetani L; Halbgebauer S; Oeckl P; Otto M; Parnetti L
    Mov Disord; 2022 Apr; 37(4):669-683. PubMed ID: 35122299
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The yin and yang of α-synuclein-associated epigenetics in Parkinson's disease.
    Pavlou MAS; Pinho R; Paiva I; Outeiro TF
    Brain; 2017 Apr; 140(4):878-886. PubMed ID: 27585855
    [TBL] [Abstract][Full Text] [Related]  

  • 53. GDNF fails to exert neuroprotection in a rat α-synuclein model of Parkinson's disease.
    Decressac M; Ulusoy A; Mattsson B; Georgievska B; Romero-Ramos M; Kirik D; Björklund A
    Brain; 2011 Aug; 134(Pt 8):2302-11. PubMed ID: 21712347
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Structure, function and toxicity of alpha-synuclein: the Bermuda triangle in synucleinopathies.
    Villar-Piqué A; Lopes da Fonseca T; Outeiro TF
    J Neurochem; 2016 Oct; 139 Suppl 1():240-255. PubMed ID: 26190401
    [TBL] [Abstract][Full Text] [Related]  

  • 55. α-Synuclein and astrocytes: tracing the pathways from homeostasis to neurodegeneration in Lewy body disease.
    Sorrentino ZA; Giasson BI; Chakrabarty P
    Acta Neuropathol; 2019 Jul; 138(1):1-21. PubMed ID: 30798354
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Alpha-synuclein propagation: New insights from animal models.
    Dehay B; Vila M; Bezard E; Brundin P; Kordower JH
    Mov Disord; 2016 Feb; 31(2):161-8. PubMed ID: 26347034
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inflammation and Parkinson's disease pathogenesis: Mechanisms and therapeutic insight.
    Forloni G; La Vitola P; Cerovic M; Balducci C
    Prog Mol Biol Transl Sci; 2021; 177():175-202. PubMed ID: 33453941
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Subcellular Parkinson's Disease-Specific Alpha-Synuclein Species Show Altered Behavior in Neurodegeneration.
    Abdullah R; Patil KS; Rosen B; Pal R; Prabhudesai S; Lee S; Basak I; Hoedt E; Yang P; Panick K; Ho HP; Chang E; Tzoulis C; Larsen JP; Neubert TA; Alves G; Møller SG
    Mol Neurobiol; 2017 Dec; 54(10):7639-7655. PubMed ID: 27837450
    [TBL] [Abstract][Full Text] [Related]  

  • 59. CD4 T cells mediate brain inflammation and neurodegeneration in a mouse model of Parkinson's disease.
    Williams GP; Schonhoff AM; Jurkuvenaite A; Gallups NJ; Standaert DG; Harms AS
    Brain; 2021 Aug; 144(7):2047-2059. PubMed ID: 33704423
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Neurodegeneration by α-synuclein-specific T cells in AAV-A53T-α-synuclein Parkinson's disease mice.
    Karikari AA; McFleder RL; Ribechini E; Blum R; Bruttel V; Knorr S; Gehmeyr M; Volkmann J; Brotchie JM; Ahsan F; Haack B; Monoranu CM; Keber U; Yeghiazaryan R; Pagenstecher A; Heckel T; Bischler T; Wischhusen J; Koprich JB; Lutz MB; Ip CW
    Brain Behav Immun; 2022 Mar; 101():194-210. PubMed ID: 35032575
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.